By Martin Quin Pollard, Laurie Chen and Yew Lun Tian BEIJING (Reuters) - For several foreign diplomats based in China, the news that President Xi ...
STORY CONTINUES BELOW THESE SALTWIRE VIDEOSBy Martin Quin Pollard, Laurie Chen and Yew Lun Tian
"That has trickle-down effects through the system where lower-level officials, bureaucrats and diplomats are less willing to go off script," said Neelam, director of public opinion and foreign policy at Lowy Institute. China has testy relations with host India, which analysts say may be a factor, but more broadly Xi's international travel has significantly dropped off this year and has been limited to countries Beijing views as friendly.
Scheduling visits for travelling dignitaries, as well as establishing protocols and ensuring media access, is also getting harder, several diplomats said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Analysis-Xi skipping G20 summit seen as new setback to India-China tiesBy YP Rajesh, Krishn Kaushik and Martin Quin Pollard NEW DELHI/BEIJING (Reuters) - Chinese President Xi Jinping's decision to skip the G20 summit is ...
Read more »
Analysis-Xi skipping G20 summit seen as new setback to India-China tiesBy YP Rajesh, Krishn Kaushik and Martin Quin Pollard NEW DELHI/BEIJING (Reuters) - Chinese President Xi Jinping's decision to skip the G20 summit is ...
Read more »
Analysis-For foreign envoys in China, Xi’s G20 absence confirms worrying trendBy Martin Quin Pollard, Laurie Chen and Yew Lun Tian BEIJING (Reuters) - For several foreign diplomats based in China, the news that President Xi ...
Read more »
Analysis-FTC settlement could shelter Amgen from US price cuts, taxesThe U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics was the latest setback to its stated goal of stricter antitrust enforcement, and instead paved the way for Amgen to gain drugs not subject to new price negotiations and possibly lower the company's tax burden. The move signals the FTC's uncertainty that a court would support its novel theory of future competition being disadvantaged by Amgen's 'bundling' of drugs in negotiations with insurers. 'I think there is some skittishness on whether to pursue this and develop new case law,' said Abiel Garcia, a partner at Kesselman, Brantly & Stockinger and a former deputy attorney general in California's antitrust department.
Read more »
Analysis-US healthcare stocks roiled by investor tug of war over economyU.S. stock fund flows into and out of the healthcare sector have swung wildly from week to week lately, as investors have adjusted their bets over how long the economy will stay strong. Many view healthcare as a defensive sector because it has constant demand and is somewhat insulated from the economy. Down nearly 2% for the year to date, healthcare has badly lagged the gain of over 17% in the S&P 500 index as U.S. economic growth has heated up to what the Atlanta Federal Reserve estimates is a booming 5.9% expansion in the third quarter.
Read more »
Analysis-US banks hold $3.3 trillion cash amid banking crisis, slowdown worriesBy Saeed Azhar and Ann Saphir NEW YORK/SAN FRANCISCO (Reuters) - U.S. lenders are holding onto large piles of cash as insurance against a slowing ...
Read more »